<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38937639</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0447</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Jun</Month><Day>27</Day></PubDate></JournalIssue><Title>Pediatric research</Title><ISOAbbreviation>Pediatr Res</ISOAbbreviation></Journal><ArticleTitle>Impact of the COVID-19 infection on children with allergic diseases in China.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41390-024-03365-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The COVID-19 pandemic has prompted investigations into the association between this novel virus and allergic diseases, particularly asthma in children. However, the nature of this relationship remains poorly established.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to determine the clinical characteristics of children with allergic diseases who have contracted COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective study was conducted at the Children's Hospital Affiliated to the Capital Institute of Pediatrics from January to March 2023. A total of 568 children aged 0-17 years diagnosed with asthma and COVID-19 infection were included. A comparative analysis of clinical characteristics was conducted between asthma and non-asthma groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Asthmatic children with COVID-19 infection showed significantly higher frequencies of cough, wheezing, expectoration, and long-term symptoms compared to those without asthma (P&#x2009;&lt;&#x2009;0.05). Subgroups with poor therapy compliance exhibited elevated proportions of cough, chest tightness, and wheezing compared to good therapy compliance (P&#x2009;&lt;&#x2009;0.05). Multivariate logistic regression identified poor therapy compliance as a risk factor for long COVID in asthmatic children.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Children with asthma secondary to COVID-19 infection were more prone to developing coughs, expectoration, and wheezing. Poor therapy compliance emerged as a significant risk factor for long COVID-19 in these individuals.</AbstractText><AbstractText Label="IMPACT" NlmCategory="CONCLUSIONS">Asthmatic children with COVID-19 infection showed significantly higher frequencies of cough, wheezing, expectoration. Poor therapy compliance was the risk factor for long COVID in asthmatic children. This article supplements the effects of different therapeutic drugs on the condition of children with asthma after infection with COVID-19 as well as the possible risk factors for the long COVID. The results of our study have important implications for public health policy makers and healthcare professionals. To understand the impact of COVID-19 on children with asthma will help guide appropriate management strategies and ensure access to necessary healthcare resources.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guoqing</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Respiratory, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huahong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Growth and Development, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sha</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Allergy, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, 100020, China. shali_zh@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Res</MedlineTA><NlmUniqueID>0100714</NlmUniqueID><ISSNLinking>0031-3998</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>28</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>28</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38937639</ArticleId><ArticleId IdType="doi">10.1038/s41390-024-03365-3</ArticleId><ArticleId IdType="pii">10.1038/s41390-024-03365-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>General Office of the National Health Commission, S. G. D. o. T. C. M. Formula for Diagnosis and Treatment of Novel Coronaviruvirus Infection (Trial Version 10)(2023 1 7) [Eb/Ol].[January 6, 2023]. (2023-1-7).</Citation></Reference><Reference><Citation>Zhang, X., Zhang, W. &amp; Chen, S. Shanghai&#x2019;s Life-Saving Efforts against the Current Omicron Wave of the Covid-19 Pandemic. Lancet 399, 2011&#x2013;2012 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00838-8</ArticleId><ArticleId IdType="pubmed">35533708</ArticleId><ArticleId IdType="pmc">9075855</ArticleId></ArticleIdList></Reference><Reference><Citation>Alduraywish, S. Covid-19 Transmission, Risks Factors and Disease Characteristics in Asthmatics Patients. Post&#x119;py Mikrobiologii - Adv. Microbiol. 61, 125&#x2013;132 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/am-2022-011</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin, D. M. G., Faner, R., Sibila, O., Badia, J. R. &amp; Agusti, A. Do Chronic Respiratory Diseases or Their Treatment Affect the Risk of Sars-Cov-2 Infection? Lancet Respir. Med. 8, 436&#x2013;438 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30167-3</ArticleId><ArticleId IdType="pubmed">32251625</ArticleId><ArticleId IdType="pmc">7270536</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang, L., Karakiulakis, G. &amp; Roth, M. Are Patients with Hypertension and Diabetes Mellitus at Increased Risk for Covid-19 Infection? Lancet Respir. Med. 8, e21 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30116-8</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId><ArticleId IdType="pmc">7118626</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, Y. D. et al. Risk Factors for Severe and Critically Ill Covid-19 Patients: A Review. Allergy 76, 428&#x2013;455 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, J. M. et al. Allergic Disorders and Susceptibility to and Severity of Covid-19: A Nationwide Cohort Study. J. Allergy Clin. Immunol. 146, 790&#x2013;798 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.08.008</ArticleId><ArticleId IdType="pubmed">32810517</ArticleId><ArticleId IdType="pmc">7428784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren, J. et al. Impact of Allergic Rhinitis and Asthma on Covid-19 Infection, Hospitalization, and Mortality. J. Allergy Clin. Immunol. Pr. 10, 124&#x2013;133 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.10.049</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom, C. I. et al. Risk of Adverse Outcomes in Patients with Underlying Respiratory Conditions Admitted to Hospital with Covid-19: A National, Multicentre Prospective Cohort Study Using the Isaric Who Clinical Characterisation Protocol UK. Lancet Respir. Med. 9, 699&#x2013;711 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00013-8</ArticleId><ArticleId IdType="pubmed">33676593</ArticleId><ArticleId IdType="pmc">8241313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, Z. et al. Association of Asthma and Its Genetic Predisposition with the Risk of Severe Covid-19. J. Allergy Clin. Immunol. 146, 327&#x2013;329.e324 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.06.001</ArticleId><ArticleId IdType="pubmed">32522462</ArticleId><ArticleId IdType="pmc">7423602</ArticleId></ArticleIdList></Reference><Reference><Citation>Keswani, A., Dhana, K., Rosenthal, J. A., Moore, D. &amp; Mahdavinia, M. Atopy Is Predictive of a Decreased Need for Hospitalization for Coronavirus Disease 2019. Ann. Allergy Asthma Immunol. 125, 479&#x2013;481 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.07.012</ArticleId><ArticleId IdType="pubmed">32693208</ArticleId><ArticleId IdType="pmc">7368420</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggert, L. E. et al. Asthma Phenotypes, Associated Comorbidities, and Long-Term Symptoms in Covid-19. Allergy 77, 173&#x2013;185 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14972</ArticleId><ArticleId IdType="pubmed">34080210</ArticleId></ArticleIdList></Reference><Reference><Citation>Habernau Mena, A. et al. Covid-19 Course in Allergic Asthma Patients: A Spanish Cohort Analysis. J. Asthma Allergy 15, 257&#x2013;264 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JAA.S344934</ArticleId><ArticleId IdType="pubmed">35228805</ArticleId><ArticleId IdType="pmc">8881918</ArticleId></ArticleIdList></Reference><Reference><Citation>Casal-Guisande, M., Comesana-Campos, A., Nunez-Fernandez, M., Torres-Duran, M. &amp; Fernandez-Villar, A. Proposal and Definition of an Intelligent Clinical Decision Support System Applied to the Prediction of Dyspnea after 12 Months of an Acute Episode of Covid-19. Biomedicines 12, 854 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12040854</ArticleId><ArticleId IdType="pubmed">38672208</ArticleId><ArticleId IdType="pmc">11047904</ArticleId></ArticleIdList></Reference><Reference><Citation>Karuturi, S. Long Covid-19: A Systematic Review. J. Assoc. Physicians India 71, 82&#x2013;94 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">38700307</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, W. J. et al. Confronting Covid-19-Associated Cough and the Post-Covid Syndrome: Role of Viral Neurotropism, Neuroinflammation, and Neuroimmune Responses. Lancet Respir. Med. 9, 533&#x2013;544 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId><ArticleId IdType="pmc">8041436</ArticleId></ArticleIdList></Reference><Reference><Citation>Garout, M. A. et al. Post-Covid-19 Syndrome: Assessment of Short- and Long-Term Post-Recovery Symptoms in Recovered Cases in Saudi Arabia. Infection 50, 1431&#x2013;1439 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01788-w</ArticleId><ArticleId IdType="pubmed">35294728</ArticleId><ArticleId IdType="pmc">8924350</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsayari, B. M. et al. COVID-19 and Its Impact on Back Pain in the Eastern Province of Saudi Arabia. Cureus 16, e57475 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38699131</ArticleId><ArticleId IdType="pmc">11065479</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Z., Stallings-Smith, S., Patel, S., Case, S. &amp; Hong, Y. R. Covid-19 Booster Vaccine Uptake and Reduced Risks for Long-Covid: A Cross-Sectional Study of a U.S. Adult Population. Vaccine 42, 3529&#x2013;3535 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2024.04.070</ArticleId><ArticleId IdType="pubmed">38670844</ArticleId></ArticleIdList></Reference><Reference><Citation>2023 Gina Report. Global Strategy for Asthma Management and Prevention[Eb/Ol].(2023&#x2011;07&#x2011;01)[2024&#x2011;01&#x2011;01]. https://ginasthma.org/wp-content/uploads/2023/07/GINA-2023-Full-report-23_07_06-WMS.pdf .</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Post-COVID Conditions: Information for. Healthcare Providers, Accessed February 1, (2024). https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html/ .</Citation></Reference><Reference><Citation>Nalbandian, A. et al. Post-Acute Covid-19 Syndrome. Nat. Med. 27, 601&#x2013;615 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId><ArticleId IdType="pmc">8893149</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, N. et al. Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet 395, 507&#x2013;513 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId><ArticleId IdType="pmc">7135076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunjaya, A. P., Allida, S. M., Di Tanna, G. L. &amp; Jenkins, C. R. Asthma and Covid-19 Risk: A Systematic Review and Meta-Analysis. Eur. Respir. J. 59, 2101209 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01209-2021</ArticleId><ArticleId IdType="pubmed">34385278</ArticleId><ArticleId IdType="pmc">8361304</ArticleId></ArticleIdList></Reference><Reference><Citation>Aveyard, P. et al. Association between Pre-Existing Respiratory Disease and Its Treatment, and Severe Covid-19: A Population Cohort Study. Lancet Respir. Med 9, 909&#x2013;923 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00095-3</ArticleId><ArticleId IdType="pubmed">33812494</ArticleId><ArticleId IdType="pmc">8016404</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolby, T. et al. Relationship between Asthma and Severe COVID-19: A National Cohort Study. Thorax 78, 120&#x2013;127 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-218629</ArticleId><ArticleId IdType="pubmed">35354646</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, B. Z. et al. Asthma Disease Status, COPD, and Covid-19 Severity in a Large Multiethnic Population. J. Allergy Clin. Immunol. Pr. 9, 3621&#x2013;3628.e3622 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.07.030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>